-
1
المؤلفون: Mallika Lala, Noboru Yamamoto, Lillian L. Siu, Dinesh P. de Alwis, Elliot Chartash, Lokesh Jain, Tommy Ruosi Li, Hesham Aboshady, Kapil Mayawala, Vikram Sinha
المصدر: European Journal of Cancer. 131:68-75
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Time Factors, Population, Urology, Cmax, Pembrolizumab, Antibodies, Monoclonal, Humanized, Models, Biological, Drug Administration Schedule, 03 medical and health sciences, Cmin, Antineoplastic Agents, Immunological, 0302 clinical medicine, Pharmacokinetics, Neoplasms, medicine, Humans, Computer Simulation, Trough Concentration, Dosing, Infusions, Intravenous, education, Randomized Controlled Trials as Topic, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Middle Aged, Clinical trial, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, business
-
2
المؤلفون: Jennifer Gwo, Mark Voskoboynik, Kapil Mayawala, Konstantin Dobrenkov, Ravit Geva, Richard Wnek, Georgina V. Long, Elliot Chartash
المصدر: CancerReferences. 126(22)
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Combination therapy, medicine.medical_treatment, Pembrolizumab, Antibodies, Monoclonal, Humanized, Gastroenterology, Receptors, Tumor Necrosis Factor, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Renal cell carcinoma, Internal medicine, Neoplasms, medicine, Humans, 030212 general & internal medicine, Adverse effect, business.industry, Immunotherapy, Middle Aged, medicine.disease, Combined Modality Therapy, Oncology, Tolerability, 030220 oncology & carcinogenesis, Pharmacodynamics, Female, business
-
3
المؤلفون: Elliot Chartash, Lokesh Jain, Dinesh P. de Alwis, Mallika Lala, Shu-Chih Su, Omobolaji Oyekunle Akala, Mizuho Kalabis, Vikram Sinha
المصدر: Cancer Research. 80:CT042-CT042
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Pembrolizumab, Clinical trial, 03 medical and health sciences, Regimen, 030104 developmental biology, 0302 clinical medicine, Pharmacokinetics, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, Every Three Weeks, media_common.cataloged_instance, Dosing, European union, business, media_common
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1d8ef5ccc60934dcfca3fe1cc81b3fcf
https://doi.org/10.1158/1538-7445.am2020-ct042 -
4
المؤلفون: Talia Golan, Karen A. Autio, Richard Wnek, Kyriakos P. Papadopoulos, Konstantin Dobrenkov, Elliot Chartash, Xiaoyun Nicole Li, Georgina V. Long
المصدر: Journal of Clinical Oncology. 37:9509-9509
مصطلحات موضوعية: Agonist, Cancer Research, biology, medicine.drug_class, business.industry, T cell, Pembrolizumab, Monoclonal antibody, 03 medical and health sciences, 0302 clinical medicine, Immune system, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, medicine, biology.protein, Cancer research, Antibody, business, Ligation, Glucocorticoid, 030215 immunology, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8cf67cf0925f0da9b39827bff995900e
https://doi.org/10.1200/jco.2019.37.15_suppl.9509 -
5
المؤلفون: Amy M Beebe, Elliot Chartash, Jennifer Gwo, Georgina V. Long, Ravit Geva, Mark Voskoboynik, Konstantin Dobrenkov
المصدر: Journal of Clinical Oncology. 36:3029-3029
مصطلحات موضوعية: 0301 basic medicine, Agonist, Cancer Research, business.industry, medicine.drug_class, chemical and pharmacologic phenomena, First in human, Pembrolizumab, Monoclonal antibody, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Cancer research, Medicine, In patient, business, Tumor necrosis factor receptor, CD8, Glucocorticoid, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::568c2d0ffbe8242a4d24c46dd6e613f2
https://doi.org/10.1200/jco.2018.36.15_suppl.3029 -
6
المؤلفون: Mallika Lala, Mengyao Li, Lokesh Jain, Vikram Sinha, Dinesh P. de Alwis, Elliot Chartash
المصدر: Journal of Clinical Oncology. 36:3062-3062
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Schedule, Multiple cancer, business.industry, Dosing regimen, Pembrolizumab, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Dosing, business, Exposure response
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7ca024c956460c8546111bf2c02f71c9
https://doi.org/10.1200/jco.2018.36.15_suppl.3062 -
7
المؤلفون: Sanjiv S. Agarwala, Emmett V. Schmidt, Biao Xing, Graeme Currie, Abraham C. F. Leung, Robert Janssen, Elliot Chartash, Rene Gonzalez, Antoni Ribas, Shivaani Kummar, John Nemunaitis, Joseph J. Drabick
المصدر: Journal of Clinical Oncology. 35:9550-9550
مصطلحات موضوعية: 0301 basic medicine, Agonist, Cancer Research, Metastatic melanoma, medicine.drug_class, business.industry, T cell, Pembrolizumab, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, Oncology, Multicenter study, 030220 oncology & carcinogenesis, Immunology, medicine, Cancer research, Open label, Anti pd1, Antigen-presenting cell, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e8b2443b7354ec72996a936c857de8ed
https://doi.org/10.1200/jco.2017.35.15_suppl.9550 -
8
المؤلفون: Julia Dai, Steven M. Townson, Satish Shanbhag, Andrei R. Shustov, Holden T. Maecker, Alain H. Rook, Shufeng Li, Steven P. Fling, Holbrook E Kohrt, Ziba Rabhar, Ash A. Alizadeh, Yi Yang, Priyanka B. Subrahmanyam, Elad Sharon, Steven M. Horwitz, Michael S. Khodadoust, Youn H. Kim, Francine M. Foss, Jinah Kim, Martin A. Cheever, Richard Shine, Jennifer H. Yearley, Alison J. Moskowitz, Elliot Chartash, Lubomir Sokol, Pierluigi Porcu
المصدر: Blood. 128:181-181
مصطلحات موضوعية: Oncology, Mycosis fungoides, medicine.medical_specialty, Surrogate endpoint, business.industry, Immunology, Phases of clinical research, Cell Biology, Hematology, Pembrolizumab, medicine.disease, Biochemistry, Clinical trial, 03 medical and health sciences, 0302 clinical medicine, Tolerability, 030220 oncology & carcinogenesis, Internal medicine, medicine, Clinical endpoint, Adverse effect, business, 030215 immunology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::00fdf177ee5a7c258a075cc69424562a
https://doi.org/10.1182/blood.v128.22.181.181 -
9
المؤلفون: Robert Janssen, C. Guiducci, Rene Gonzalez, Elliot Chartash, R. Coffman, C.J. Berman, Albert Candia, John Nemunaitis, Joseph J. Drabick, Shivaani Kummar, Antoni Ribas, Sanjiv S. Agarwala, Emmett V. Schmidt
المصدر: Annals of Oncology. 27:vi365
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Metastatic melanoma, business.industry, Hematology, Pembrolizumab, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Dose escalation, In patient, Open label, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1289f92526457a77d5963f8f4fe6f384
https://doi.org/10.1093/annonc/mdw378.21